Navigation Links
New test shows promise for accurate diagnosis of Turner syndrome
Date:2/16/2011

As a child grows, a short stature is not usually cause for concern, but it is often the only sign of a condition called Turner syndrome. Prevalent in girls, Turner syndrome is a genetic defect that short-circuits normal growth and leads to cardiac and renal problems. It is not commonly detected until age 10 or older when a youngster's unusually short height raises suspicions.

This lag before diagnosis of the condition can delay the start of growth hormone therapy, which can help in achieving normal or near-normal adult stature. Yale School of Medicine researchers are aiming to close this lag time with a new inexpensive, accurate and practical diagnostic test for Turner syndrome that can be done in a doctor's office. Their research is published online and in an upcoming March 2011 print issue of The Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

"We've developed a practical test that can be used to test large numbers of girls, and is much quicker and less expensive than the current method called cytogenetic analysis by karyotype," said the study's lead author Scott Rivkees, M.D., professor of pediatrics at Yale School of Medicine. "The new test would also provide the benefit of early detection of other health conditions associated with TS, such as potential renal and cardiac problems."

Turner syndrome occurs when an X-chromosome is completely or partially deleted. The syndrome affects one in 1,500 to 2,000 females. Untreated girls with TS achieve an average height of 4 feet, 8 inches.

Rivkees and his co-authors developed the test based on a quantitative method of genotyping to detect X-chromosome abnormalities. The test was developed and validated from DNA samples from more than 500 individuals. Of 90 clinically confirmed TS individuals tested, the assay correctly identified 87.

"Because of the small amount of DNA needed for the test, sample DNA can be extracted from cheek swabs, or from newborn screening blood spots that are routinely collected," Rivkees said. "If broadly used in the clinical setting at young ages, this test can prevent the delayed recognition of TS."

A U.S. patent was recently issued to Yale University for "DNA Diagnostic Screening for Turner Syndrome and Sex Chromosome Disorders."


'/>"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
Source:Eurekalert

Related biology news :

1. Long-term study shows effect of climate change on animal diversity
2. New approach to treating cystic fibrosis lung infection shows promise
3. Research shows Brazilian acai berry antioxidants absorbed by human body
4. Wildfires cause ozone pollution to violate health standards, new study shows
5. New CU-Boulder study shows diversity decreases chances of parasitic disease
6. U of MN study shows link between gene variations and cancer survival
7. New study shows drinking your vegetables may be a solution to bridging the vegetable gap
8. Mounting evidence shows health benefits of grape polyphenols
9. Research shows that the pill does not deserve its reputation for causing weight gain
10. New journal shows half-broken gene is enough to cause cancer
11. Research shows that time invested in practicing pays off for young musicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... -- KEY FINDINGS The global market for ... of 25.76% during the forecast period of 2017-2025. The ... the growth of the stem cell market. ... INSIGHTS The global stem cell market is segmented on ... stem cell market of the product is segmented into ...
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
(Date:3/30/2017)... The research team of The Hong Kong ... identification by adopting ground breaking 3D fingerprint minutiae recovery and matching ... and accuracy for use in identification, crime investigation, immigration control, security ... ... A research team led by ...
Breaking Biology News(10 mins):
(Date:8/16/2017)... ... August 16, 2017 , ... Recent ... cell type. Many treatments for specific cancers, such as breast, prostate, or lung, ... is androgen deprivation therapy for advanced prostate cancer. , This therapy limits ...
(Date:8/16/2017)... ... August 16, 2017 , ... Today, 3Bar ... has secured $2M in funding from an impressive group of investors, including Rev1 ... Thrive Fund. With this investment, 3Bar is broadening availability of its groundbreaking offering ...
(Date:8/16/2017)... edition of the Inc. 5000 features a now-familiar name: BioPoint ( http://biopointinc.com/ ... list for the third year in a row. Now in its 36th ... a set of quantitative metrics. In addition, BioPoint was also named to ... Bay State . ... ...
(Date:8/15/2017)... , Aug. 15, 2017 After spending the past ... support with crowdsourced data collection, GeneFo now offers this platform to ... aligning and amplifying support, adherence, and data collection vis a vis ... foundations mark the successful launch of this offer. ... GeneFo ...
Breaking Biology Technology: